BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23828315)

  • 1. Intraductal papillary neoplasms of the bile duct: stepwise progression to carcinoma involves common molecular pathways.
    Schlitter AM; Born D; Bettstetter M; Specht K; Kim-Fuchs C; Riener MO; Jeliazkova P; Sipos B; Siveke JT; Terris B; Zen Y; Schuster T; Höfler H; Perren A; Klöppel G; Esposito I
    Mod Pathol; 2014 Jan; 27(1):73-86. PubMed ID: 23828315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract.
    Abraham SC; Lee JH; Hruban RH; Argani P; Furth EE; Wu TT
    Hum Pathol; 2003 Sep; 34(9):902-10. PubMed ID: 14562286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
    Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is a marker that predicts presence of invasion in papillary biliary tumors.
    Sasaki M; Sato Y
    Hum Pathol; 2017 Apr; 62():152-159. PubMed ID: 28089541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GNAS Is frequently mutated in a specific subgroup of intraductal papillary neoplasms of the bile duct.
    Tsai JH; Yuan RH; Chen YL; Liau JY; Jeng YM
    Am J Surg Pathol; 2013 Dec; 37(12):1862-70. PubMed ID: 24061513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K; Fukumoto T; Ajiki T; Otani K; Kanzawa M; Akita M; Kido M; Ku Y; Itoh T; Zen Y
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary neoplasm of the bile duct.
    Wan XS; Xu YY; Qian JY; Yang XB; Wang AQ; He L; Zhao HT; Sang XT
    World J Gastroenterol; 2013 Dec; 19(46):8595-604. PubMed ID: 24379576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholangiocarcinoma with intraductal tubular growth pattern versus intraductal papillary growth pattern.
    Tsukahara T; Shimoyama Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nakamura S; Nagino M
    Mod Pathol; 2016 Mar; 29(3):293-301. PubMed ID: 26769137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas?
    Rocha FG; Lee H; Katabi N; DeMatteo RP; Fong Y; D'Angelica MI; Allen PJ; Klimstra DS; Jarnagin WR
    Hepatology; 2012 Oct; 56(4):1352-60. PubMed ID: 22504729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
    Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
    Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.
    Sasaki M; Matsubara T; Nitta T; Sato Y; Nakanuma Y
    PLoS One; 2013; 8(12):e81706. PubMed ID: 24312577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation and immunohistochemical profile in intraductal papillary neoplasm of the intrahepatic bile ducts.
    Xian ZH; Qin C; Cong WM
    Pathol Res Pract; 2018 Jan; 214(1):105-111. PubMed ID: 29103773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma.
    Nakanuma Y; Uchida T; Sato Y; Uesaka K
    Hum Pathol; 2017 Feb; 60():46-57. PubMed ID: 27984121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases.
    Schlitter AM; Jang KT; Klöppel G; Saka B; Hong SM; Choi H; Offerhaus GJ; Hruban RH; Zen Y; Konukiewitz B; Regel I; Allgäuer M; Balci S; Basturk O; Reid MD; Esposito I; Adsay V
    Mod Pathol; 2015 Sep; 28(9):1249-64. PubMed ID: 26111977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Konishi F; Masuda S; Mitsui T; Asada Y; Miura S; Miyayama S; Uehara T; Katsuyama T; Ohta T; Minato H; Nakanuma Y
    Mod Pathol; 2006 Sep; 19(9):1243-54. PubMed ID: 16741522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas.
    Zen Y; Fujii T; Itatsu K; Nakamura K; Minato H; Kasashima S; Kurumaya H; Katayanagi K; Kawashima A; Masuda S; Niwa H; Mitsui T; Asada Y; Miura S; Ohta T; Nakanuma Y
    Hepatology; 2006 Nov; 44(5):1333-43. PubMed ID: 17058219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
    Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
    Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.
    Matthaei H; Wu J; Dal Molin M; Debeljak M; Lingohr P; Katabi N; Klimstra DS; Adsay NV; Eshleman JR; Schulick RD; Kinzler KW; Vogelstein B; Hruban RH; Maitra A
    HPB (Oxford); 2012 Oct; 14(10):677-83. PubMed ID: 22954004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.